MOLECULAR CHARACTERIZATION OF PERFORIN GENE REGULATION

穿孔素基因调控的分子特征

基本信息

项目摘要

DESCRIPTION (Adapted from Investigator's abstract): Natural killer (NK) cells and cytotoxic T lymphocytes (CTL) defeat immunogenic tumors and virus infections. Physiologically, most CTL reside in the body as pre-effectors (pre-CTL) that are unable to kill. When the immune system is confronted with intracellular pathogens, preCTL are expanded and armed. During this process many genes are newly expressed or upregulated in preCTL, leading to their proliferation and differentiation into effector CTL(eff CTL). One of these genes is perforin, a membrane "perforating" killer molecule essential for the function of the adaptive immune system. In contrast, NK cells, perhaps best thought of as primordial CTL that lack receptors for a specific antigen, constitutively express perforin and kill without activation. Our experiments have shown that perforin gene expression is determined at the transcriptional level and that this process requires regulatory domains in addition to the promoter. This application will continue to identify and characterize these regulatory domains by elucidating constitutive and inducible nuclear events at the perforin gene locus in NK cells and CTL. Molecules involved in this process ultimately may be of therapeutical use or may become therapeutical targets. From the immunological and developmental point of view, the regulatory domains ultimately may shed light on transcription factors that control not only the perforin gene but also the commitment to and progression of the perforin expressing lineages during hematolymphopoiesis. This application specifically proposes to: 1) explore the presence of additional regulatory domains within the boundaries of an active perforin gene locus in tumor cell lines; 2) characterize the function of potential regulatory domains in tumor cell lines; and 3) demonstrate the function of the regulatory domains in normal cells. To achieve these aims we will: 1) perform a DNase I sensitivity and hypersensitivity analysis of the perforin gene locus; 2) analyze potential regulatory domains by reporter gene assays; and 3) generate and analyze mice that are transgenic for regulatory DNAs identified in the first two aims.
描述(改编自调查员摘要):自然杀手(NK)

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Mathias Georg Lichtenheld其他文献

Mathias Georg Lichtenheld的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Mathias Georg Lichtenheld', 18)}}的其他基金

MOLECULAR CHARACTERIZATION OF PERFORIN GENE REGULATION
穿孔素基因调控的分子特征
  • 批准号:
    2096915
  • 财政年份:
    1992
  • 资助金额:
    $ 20.12万
  • 项目类别:
MOLECULAR CHARACTERIZATION OF PERFORIN GENE REGULATION
穿孔素基因调控的分子特征
  • 批准号:
    2894919
  • 财政年份:
    1992
  • 资助金额:
    $ 20.12万
  • 项目类别:
MOLECULAR CHARACTERIZATION OF PERFORIN GENE REGULATION
穿孔素基因调控的分子特征
  • 批准号:
    2096916
  • 财政年份:
    1992
  • 资助金额:
    $ 20.12万
  • 项目类别:
MOLECULAR CHARACTERIZATION OF PERFORIN GENE REGULATION
穿孔素基因调控的分子特征
  • 批准号:
    6375921
  • 财政年份:
    1992
  • 资助金额:
    $ 20.12万
  • 项目类别:
MOLECULAR CHARACTERIZATION OF PERFORIN GENE REGULATION
穿孔素基因调控的分子特征
  • 批准号:
    2619435
  • 财政年份:
    1992
  • 资助金额:
    $ 20.12万
  • 项目类别:
MOLECULAR CHARACTERIZATION OF PERFORIN GENE REGULATION
穿孔素基因调控的分子特征
  • 批准号:
    2096917
  • 财政年份:
    1992
  • 资助金额:
    $ 20.12万
  • 项目类别:
MOLECULAR CHARACTERIZATION OF PERFORIN GENE REGULATION
穿孔素基因调控的分子特征
  • 批准号:
    3460419
  • 财政年份:
    1992
  • 资助金额:
    $ 20.12万
  • 项目类别:
MOLECULAR CHARACTERIZATION OF PERFORIN GENE REGULATION
穿孔素基因调控的分子特征
  • 批准号:
    6171876
  • 财政年份:
    1992
  • 资助金额:
    $ 20.12万
  • 项目类别:
MOLECULAR CHARACTERIZATION OF PERFORIN GENE REGULATION
穿孔素基因调控的分子特征
  • 批准号:
    3460418
  • 财政年份:
    1992
  • 资助金额:
    $ 20.12万
  • 项目类别:

相似海外基金

The molecular basis of T cell receptor cross-reactivity between MHC and MR1
MHC 和 MR1 之间 T 细胞受体交叉反应的分子基础
  • 批准号:
    DP240102905
  • 财政年份:
    2024
  • 资助金额:
    $ 20.12万
  • 项目类别:
    Discovery Projects
Machine Learning of Disease Biomarkers from B and T cell Receptor Repertoires
来自 B 和 T 细胞受体库的疾病生物标志物的机器学习
  • 批准号:
    23K28188
  • 财政年份:
    2024
  • 资助金额:
    $ 20.12万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
CAREER: Understanding the Impact of Dephosphorylation Kinetics and Adapter Specificity on Synthetic T Cell Receptor Signaling and Function
职业:了解去磷酸化动力学和接头特异性对合成 T 细胞受体信号传导和功能的影响
  • 批准号:
    2339172
  • 财政年份:
    2024
  • 资助金额:
    $ 20.12万
  • 项目类别:
    Continuing Grant
Special Public T Cell Receptor Sequences that Predict Outcomes for Cancer Patients
预测癌症患者预后的特殊公共 T 细胞受体序列
  • 批准号:
    10577518
  • 财政年份:
    2023
  • 资助金额:
    $ 20.12万
  • 项目类别:
Machine Learning of Disease Biomarkers from B and T cell Receptor Repertoires
来自 B 和 T 细胞受体库的疾病生物标志物的机器学习
  • 批准号:
    23H03498
  • 财政年份:
    2023
  • 资助金额:
    $ 20.12万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Impact of T cell receptor signaling on memory CD8+ T cell stemness
T 细胞受体信号传导对记忆 CD8 T 细胞干性的影响
  • 批准号:
    10676407
  • 财政年份:
    2023
  • 资助金额:
    $ 20.12万
  • 项目类别:
T cell receptor cross-reactivity and structural basis of virus immune escape
T细胞受体交叉反应性和病毒免疫逃逸的结构基础
  • 批准号:
    22KK0277
  • 财政年份:
    2023
  • 资助金额:
    $ 20.12万
  • 项目类别:
    Fund for the Promotion of Joint International Research (Fostering Joint International Research (A))
T-cell receptor mimic affinity reagent generation using an in vivo novel immunogen strategy
使用体内新型免疫原策略生成 T 细胞受体模拟亲和试剂
  • 批准号:
    10599584
  • 财政年份:
    2023
  • 资助金额:
    $ 20.12万
  • 项目类别:
Mechanical regulation of T cell receptor and co-receptor responses in cancer immunotherapy
癌症免疫治疗中 T 细胞受体和辅助受体反应的机械调节
  • 批准号:
    10530023
  • 财政年份:
    2022
  • 资助金额:
    $ 20.12万
  • 项目类别:
Inhibition of T-cell Receptor Signaling for Treatment of Adult T-cell Leukemia Lymphoma
抑制 T 细胞受体信号转导治疗成人 T 细胞白血病淋巴瘤
  • 批准号:
    10684172
  • 财政年份:
    2022
  • 资助金额:
    $ 20.12万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了